Global View: Infosys, Aurobindo Pharma, United Spirits, Astral and Dixon Tech can give 6-49% return
Indian markets on Tuesday made a flat opening as Nifty opened near 16600 levels and Sensex 55,600. Nifty Metal and FMCG were top sectoral gainers in early morning trade.
Indian markets on Tuesday made a flat opening as Nifty opened near 16600 levels and Sensex 55,600. Nifty Metal and FMCG were top sectoral gainers in early morning trade.
Investors may see a stock-specific action in Infosys, Aurobindo Pharma, United Spirits, Astral and Dixon Tech, in which global brokerages came out with their reports on business development, or earnings outlook.
Infosys – Upside of 36%
Most of the global brokerages are bullish on the IT major Infosys. CLSA maintained a Buy rating with a target price of Rs 2040 per share, it said no macro headwinds for the company, besides, the digital and cloud strategy of the company gives comfort with respect to margins on long-term basis.
Image Source - Reuters
Similarly, Credit Suisse with Outperform rating and Jefferies with a Buy rating gives the same target of Rs 2050 per share, while HSBC upgrades to Buy from Hold with a target price of Rs 1940 per share. The stock of Infosys on Tuesday closed at around Rs 1503 per share.
Aurobindo Pharma – Upside of 49%
The majority of global brokerages have cut their target price for Aurobindo. Goldman Sachs with a Buy rating reduces the target price to Rs 720 from Rs 840 per share. Similarly, CITI also gives a Buy rating with a lower target price of Rs 710 from Rs 860 per share.
Image Source - Pixabay
While Credit Suisse maintained Outperform rating with a target price of Rs 790 from Rs 855 per share. The stock on Tuesday closed at Rs 531 per share.
United Spirits – Upside of 6%
Macquarie with Underperform rating sets a target of Rs 640 per share, while CITI and Credit Suisse both maintained a Neutral for a target of Rs 860 and Rs 900 per share respectively. Credit Suisse said the popular brands’ strategic sale is favourable move, while margins headwinds persist near-term.
Image Source - Reuters
Astral Ltd – Upside of 6%
CLSA upgrade Astral to Underperform with a target price of Rs 1827 per share, while Jefferies suggested to Hold with a reduced target of Rs 1840 from Rs 2000 per share. The stock on Tuesday closed at Rs 1730 per share.
Image Source - Official Website
Dixon Tech – Upside of 24%
On Dixon Tech, Credit Suisse maintained an Outperform rating with a target of Rs 4800 per share. On the contrary, Morgan Stanley also maintained Outperform rating with a below-market price target of Rs 2879 per share. The stock on Tuesday closed at Rs 3858 per share.
Image Source - Official Twitter